Lv51
1540 积分 2022-05-17 加入
[Chinese expert consensus on early diagnosis and treatment of esophageal cancer]
2小时前
已完结
Abstract CT075: Updated overall survival outcomes from a randomized, double-blind phase III study of sintilimab versus placebo in combination with chemotherapy as first-line treatment for advanced esophageal squamous cell carcinoma (ORIENT-15)
1个月前
已关闭
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study
3个月前
已完结
皖公网安备34019202002308
